McCarron RM, Shapiro B, Rawles J, Luo J (2021) Depression. Ann Intern Med 174:ITC65–ITC80
Mazza MG, Palladini M, Poletti S, Benedetti F (2022) Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs 36:681–702
Article CAS PubMed Central Google Scholar
Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ (2023) Pharmacotherapy for treatment-resistant depression: antidepressants and atypical antipsychotics. Psychiatr Clin North Am 46:261–275
Sampogna G et al (2024) New trends in personalized treatment of depression. Curr Opin Psychiatry 37:3–8
Jha MK, Mathew SJ (2023) Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry 180:190–199
Marwaha S et al (2023) Novel and emerging treatments for major depression. Lancet 401:141–153
Rush AJ et al (2022) Clinical research challenges posed by difficult-to-treat depression. Psychol Med 52:419–432
Article PubMed Central Google Scholar
Dean J, Keshavan M (2017) The neurobiology of depression: an integrated view. Asian J Psychiatr 27:101–111
Harsanyi S et al (2022) Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int J Mol Sci 24:578
Article PubMed Central Google Scholar
Hirschfeld RM (2000) History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 61:4–6
Boku S et al (2018) Neural basis of major depressive disorder: beyond monoamine hypothesis. Psychiatry Clin Neurosci 72:3–12
Jesulola E, Micalos P, Baguley IJ (2018) Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model — are we there yet? Behav Brain Res 341:79–90
Carvalho AF et al (2016) The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85:270–288
Papakostas GI (2008) Tolerability of modern antidepressants. J Clin Psychiatry 69:215–265
Thase ME (2012) Using adjunctive treatments when first-line antidepressants fail. J Clin Psychiatry 73:e01
Zhong W, Zhang Q (2024) Atractylodin: an alkyne compound with anticancer potential. Am J Chin Med 52:1729–1757
Ye Q et al (2023) Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis. Heliyon 9:e18321
Article CAS PubMed Central Google Scholar
Heo G et al (2023) Atractylodin ameliorates colitis via PPARα agonism. Int J Mol Sci 24:802
Article CAS PubMed Central Google Scholar
Zhang T et al (2022) Atractylodin induces apoptosis and inhibits the migration of A549 lung cancer cells by regulating ROS-mediated signaling pathways. Molecules 27:2946
Article CAS PubMed Central Google Scholar
Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266–282
Article PubMed Central Google Scholar
Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107–125
Li J et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88
Article PubMed Central Google Scholar
Pope LE, Dixon SJ (2023) Regulation of ferroptosis by lipid metabolism. Trends Cell Biol 33:1077–1087
Article CAS PubMed Central Google Scholar
Sasmita AO et al (2018) Harnessing neuroplasticity: modern approaches and clinical future. Int J Neurosci 128:1061–1077
Kong NW, Gibb WR, Tate MC (2016) Neuroplasticity: insights from patients harboring gliomas. Neural Plast 2016:2365063
Article PubMed Central Google Scholar
Ma J et al (2024) Understanding the mechanism of ferroptosis in neurodegenerative diseases Front. Biosci. (Landmark Ed.) 29:291
Jacquemyn J, Ralhan I, Ioannou MS (2024) Driving factors of neuronal ferroptosis. Trends Cell Biol 34:535–546
Wilton DK, Dissing-Olesen L, Stevens B (2019) Neuron-glia signaling in synapse elimination. Annu Rev Neurosci 42:107–127
Marinelli S, Basilico B, Marrone MC, Ragozzino D (2019) Microglia-neuron crosstalk: signaling mechanism and control of synaptic transmission. Semin Cell Dev Biol 94:138–151
Zheng D et al (2022) ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol 13:1039241
Article CAS PubMed Central Google Scholar
Wang B et al (2023) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97:1439–1451
Sun Y et al (2022) Mechanisms of ferroptosis and emerging links to the pathology of neurodegenerative diseases. Front Aging Neurosci 14:904152
Article CAS PubMed Central Google Scholar
Wang ZL et al (2022) Ferroptosis in Parkinson’s disease: glia-neuron crosstalk. Trends Mol Med 28:258–269
Zhai X et al (2024) Silver nanoparticles induce iron accumulation-associated cognitive impairment via modulating neuronal ferroptosis. Environ Pollut 346:123555
Ménard C, Hodes GE, Russo SJ (2016) Pathogenesis of depression: insights from human and rodent studies. Neuroscience 321:138–162
Simon GE, Moise N, Mohr DC (2024) Management of depression in adults: a review. JAMA 332:1306
Rotenstein LS et al (2016) Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. JAMA 316:2214–2236
Article PubMed Central Google Scholar
Berk M et al (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200
Article PubMed Central Google Scholar
Kverno KS, Mangano E (2021) Treatment-resistant depression: approaches to treatment. J Psychosoc Nurs Ment Health Serv 59:7–11
Xu M, Zhang D, Yan J (2024) Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases. Phytomedicine 130:155738
Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82:2215–2227
Article CAS PubMed Central Google Scholar
Galaris D, Barbouti A, Pantopoulos K (2019) Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta Mol Cell Res 1866:118535
Comments (0)